Pub Date : 2020-11-01DOI: 10.1097/01.CCN.0000718332.38919.36
A. Hafer, Lindsay McCann
Abstract: The rise in direct oral anticoagulant (DOAC) use means nurses must understand the reversal of these agents in case of bleeding. Depending on bleed severity, as well as other criteria, pharmacologic reversal can be considered in place of supportive care alone. Knowledge of literature surrounding DOAC reversal is crucial. The rise in direct oral anticoagulant (DOAC) use means nurses must understand how to reverse these agents in case of bleeding. Depending on bleed severity and other criteria, pharmacologic reversal can be considered in place of supportive care alone. This article takes an in-depth look at the options.
{"title":"Direct oral anticoagulant reversal: An update","authors":"A. Hafer, Lindsay McCann","doi":"10.1097/01.CCN.0000718332.38919.36","DOIUrl":"https://doi.org/10.1097/01.CCN.0000718332.38919.36","url":null,"abstract":"Abstract: The rise in direct oral anticoagulant (DOAC) use means nurses must understand the reversal of these agents in case of bleeding. Depending on bleed severity, as well as other criteria, pharmacologic reversal can be considered in place of supportive care alone. Knowledge of literature surrounding DOAC reversal is crucial. The rise in direct oral anticoagulant (DOAC) use means nurses must understand how to reverse these agents in case of bleeding. Depending on bleed severity and other criteria, pharmacologic reversal can be considered in place of supportive care alone. This article takes an in-depth look at the options.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48383836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-01DOI: 10.1097/01.ccn.0000718336.62517.cf
{"title":"Let's take care of one another","authors":"","doi":"10.1097/01.ccn.0000718336.62517.cf","DOIUrl":"https://doi.org/10.1097/01.ccn.0000718336.62517.cf","url":null,"abstract":"","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48639910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-01DOI: 10.1097/01.CCN.0000694088.53640.53
L. Taheri, Farzad Poorgholami, A. Zare, M. K. Jahromi
November l Nursing2020CriticalCare l 7 Changes in disease patterns that have led to a decrease in infectious diseases and an increase in life expectancy in patients with chronic diseases have refocused the public’s attention on new health concepts in recent decades.1 Scholars have stated that the focus of healthcare in the present century is improving quality of life and health for patients.2 In recent years, interest in evaluating and improving the quality of life of patients with chronic diseases has grown. The results of clinical trials have shown that quality of life can be considered an indicator of healthcare, providing more information about the health status of patients.3 In general, reducing the attenuation and disability ratio in patients with atrial fibrillation (AF) has been the focus of treatment. Few studies have been conducted on the impact of the disease and its treatments on health-related quality of life.4 AF is a type of supraventricular dysrhythmia and the most common cardiac dysrhythmia. The dysrhythmia affects more than 1% of adults, and prevalence increases with age; it occurs in 9% of people over age 80.5,6 By 2050, the rate of AF is predicted to be 2.5 times higher than present.7 AF can cause adverse reactions such as hemodynamic instability, venous thromboembolism, increased postoperative stroke, and increased hospitalization or recovery time.8,9 Although not generally a lifethreatening disorder, AF causes gradual disruption of patients’ quality of life.10 AF causes signs and symptoms including palpitations, shortness of breath, and fatigue. Therefore, the quality of life in patients with AF is Abstract: Atrial fibrillation (AF) is one of the most common cardiac dysrhythmias. This study aimed to determine the quality of life of patients with AF referred to the Al Zahra Heart Hospital in Shiraz, Iran. The authors used an AF-specific questionnaire to measure patients’ responses regarding three specific dimensions of these patients’ quality of life.
{"title":"Quality of life in patients with atrial fibrillation","authors":"L. Taheri, Farzad Poorgholami, A. Zare, M. K. Jahromi","doi":"10.1097/01.CCN.0000694088.53640.53","DOIUrl":"https://doi.org/10.1097/01.CCN.0000694088.53640.53","url":null,"abstract":"November l Nursing2020CriticalCare l 7 Changes in disease patterns that have led to a decrease in infectious diseases and an increase in life expectancy in patients with chronic diseases have refocused the public’s attention on new health concepts in recent decades.1 Scholars have stated that the focus of healthcare in the present century is improving quality of life and health for patients.2 In recent years, interest in evaluating and improving the quality of life of patients with chronic diseases has grown. The results of clinical trials have shown that quality of life can be considered an indicator of healthcare, providing more information about the health status of patients.3 In general, reducing the attenuation and disability ratio in patients with atrial fibrillation (AF) has been the focus of treatment. Few studies have been conducted on the impact of the disease and its treatments on health-related quality of life.4 AF is a type of supraventricular dysrhythmia and the most common cardiac dysrhythmia. The dysrhythmia affects more than 1% of adults, and prevalence increases with age; it occurs in 9% of people over age 80.5,6 By 2050, the rate of AF is predicted to be 2.5 times higher than present.7 AF can cause adverse reactions such as hemodynamic instability, venous thromboembolism, increased postoperative stroke, and increased hospitalization or recovery time.8,9 Although not generally a lifethreatening disorder, AF causes gradual disruption of patients’ quality of life.10 AF causes signs and symptoms including palpitations, shortness of breath, and fatigue. Therefore, the quality of life in patients with AF is Abstract: Atrial fibrillation (AF) is one of the most common cardiac dysrhythmias. This study aimed to determine the quality of life of patients with AF referred to the Al Zahra Heart Hospital in Shiraz, Iran. The authors used an AF-specific questionnaire to measure patients’ responses regarding three specific dimensions of these patients’ quality of life.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000694088.53640.53","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48678231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-10-05DOI: 10.1097/01.ccn.0000718348.91179.f6
Kevin Tishkowski, Vikas Gupta
The erythrocyte sedimentation rate (sedimentation rate, sed rate, and ESR for short) is a common hematology test that may indicate and monitor an increase in inflammatory activity within the body caused by one or more conditions such as autoimmune disease, infections or tumors. The ESR is not specific for any one disease but is used in combination with other tests to determine the presence of increased inflammatory activity. The ESR has long been used as a "sickness indicator" due to its reproducibility and low cost. Over many decades, several methods have evolved to perform the test. However, the reference method for measuring the ESR proposed by the International Committee for Standardization in Haematology (ICSH) is based on the findings described by Westergren a century ago. Newer automated systems using closed blood collection tubes and automatic readers have been introduced into laboratories to decrease the biohazardous risk to operators and to decrease the time that it takes to perform the ESR.The Westergren method measures the distance (in millimeters) at which red blood cells in anticoagulated whole blood fall to the bottom of a standardized, upright, elongated tube over one hour due to the influence of gravity. The tube used for the test is called the Westergren tube. Today, these tubes are made of either glass or plastic, with an internal diameter of 2.5 mm and lengths of 190 to 300 mm long.Perhaps the first to notice a change in the sedimentation of blood due to illness was a British surgeon John Hunter (1728–93) in his posthumous publication A Treatise on the Blood, Inflammation, and Gun-Shot Wounds. A Polish physician, Edmund Faustyn Biernacki (1866–1911), later refined the clinical use of the ESR near the end of the 19 century. Biernacki detailed his findings in 2 articles in 1897 (the Gazeta Lekarska in Poland and the Deutsche Medizinische Wochenschrift in Germany), and he developed his test for measurements. These findings were not widely propagated in the English speaking medical communities. Because of his work, the ESR is occasionally referred to as the Biernacki Reaction world-wide.The applied use of ESR in clinical diagnostics by Biernacki was furthered refined by Dr. Robert Fahraeus in 1918 and by Dr. Alf Vilhelm Albertsson Westergren in 1921. Dr. Westergren defined the standard measurement of the ESR that is still in use today. Together, Robert Fahraeus and Alf Vilhelm Albertsson Westergren are often remembered for the test, historically called the Fahraeus-Westergren test (FW test or Westergren test), which uses a standardized tube and sodium citrate anticoagulated blood. The Westergren method for measuring the ESR proposed by the International Committee for Standardization in Haematology (ICSH) has allowed reproducibility for almost a century. Over time, the use of this same method has established comparable reference values within the same laboratory and even between different facilities across the globe. The Westergren
{"title":"Erythrocyte sedimentation rate","authors":"Kevin Tishkowski, Vikas Gupta","doi":"10.1097/01.ccn.0000718348.91179.f6","DOIUrl":"https://doi.org/10.1097/01.ccn.0000718348.91179.f6","url":null,"abstract":"The erythrocyte sedimentation rate (sedimentation rate, sed rate, and ESR for short) is a common hematology test that may indicate and monitor an increase in inflammatory activity within the body caused by one or more conditions such as autoimmune disease, infections or tumors. The ESR is not specific for any one disease but is used in combination with other tests to determine the presence of increased inflammatory activity. The ESR has long been used as a \"sickness indicator\" due to its reproducibility and low cost. Over many decades, several methods have evolved to perform the test. However, the reference method for measuring the ESR proposed by the International Committee for Standardization in Haematology (ICSH) is based on the findings described by Westergren a century ago. Newer automated systems using closed blood collection tubes and automatic readers have been introduced into laboratories to decrease the biohazardous risk to operators and to decrease the time that it takes to perform the ESR.The Westergren method measures the distance (in millimeters) at which red blood cells in anticoagulated whole blood fall to the bottom of a standardized, upright, elongated tube over one hour due to the influence of gravity. The tube used for the test is called the Westergren tube. Today, these tubes are made of either glass or plastic, with an internal diameter of 2.5 mm and lengths of 190 to 300 mm long.Perhaps the first to notice a change in the sedimentation of blood due to illness was a British surgeon John Hunter (1728–93) in his posthumous publication A Treatise on the Blood, Inflammation, and Gun-Shot Wounds. A Polish physician, Edmund Faustyn Biernacki (1866–1911), later refined the clinical use of the ESR near the end of the 19 century. Biernacki detailed his findings in 2 articles in 1897 (the Gazeta Lekarska in Poland and the Deutsche Medizinische Wochenschrift in Germany), and he developed his test for measurements. These findings were not widely propagated in the English speaking medical communities. Because of his work, the ESR is occasionally referred to as the Biernacki Reaction world-wide.The applied use of ESR in clinical diagnostics by Biernacki was furthered refined by Dr. Robert Fahraeus in 1918 and by Dr. Alf Vilhelm Albertsson Westergren in 1921. Dr. Westergren defined the standard measurement of the ESR that is still in use today. Together, Robert Fahraeus and Alf Vilhelm Albertsson Westergren are often remembered for the test, historically called the Fahraeus-Westergren test (FW test or Westergren test), which uses a standardized tube and sodium citrate anticoagulated blood. The Westergren method for measuring the ESR proposed by the International Committee for Standardization in Haematology (ICSH) has allowed reproducibility for almost a century. Over time, the use of this same method has established comparable reference values within the same laboratory and even between different facilities across the globe. The Westergren","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47589549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-01DOI: 10.1097/01.ccn.0000694104.93935.d6
Jessica Rong
{"title":"End-of-life care in the ICU","authors":"Jessica Rong","doi":"10.1097/01.ccn.0000694104.93935.d6","DOIUrl":"https://doi.org/10.1097/01.ccn.0000694104.93935.d6","url":null,"abstract":"","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.ccn.0000694104.93935.d6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44579013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-01DOI: 10.1097/01.ccn.0000694116.01262.aa
P. Mccabe
Angry outbursts, harassment, shouting, swearing, verbal and/or physical threats or altercations with visitors, family members, patients, and other healthcare personnel are all forms of workplace violence. Workplace violence (WPV) has been defined by the Occupational Safety and Health Administration (OSHA) as any physical assault, threatening behavior, or verbal abuse that occurs at work.1,2 In recent years,
{"title":"Designing a workplace violence prevention and recovery program","authors":"P. Mccabe","doi":"10.1097/01.ccn.0000694116.01262.aa","DOIUrl":"https://doi.org/10.1097/01.ccn.0000694116.01262.aa","url":null,"abstract":"Angry outbursts, harassment, shouting, swearing, verbal and/or physical threats or altercations with visitors, family members, patients, and other healthcare personnel are all forms of workplace violence. Workplace violence (WPV) has been defined by the Occupational Safety and Health Administration (OSHA) as any physical assault, threatening behavior, or verbal abuse that occurs at work.1,2 In recent years,","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46944233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-01DOI: 10.1097/01.ccn.0000668564.81987.a0
Sandy L Arneson, Deena Denman, M. Mercier
{"title":"Virtual critical care nursing","authors":"Sandy L Arneson, Deena Denman, M. Mercier","doi":"10.1097/01.ccn.0000668564.81987.a0","DOIUrl":"https://doi.org/10.1097/01.ccn.0000668564.81987.a0","url":null,"abstract":"","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.ccn.0000668564.81987.a0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41496677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-01DOI: 10.1097/01.CCN.0000694084.86350.93
E. Franges
ABSTRACT Incomplete spinal cord injury is challenging to diagnose and treat. This overview of Brown-Séquard syndrome outlines key assessment and nursing considerations important to enhancing recovery outcomes.
{"title":"Solving the puzzle of Brown-Séquard syndrome.","authors":"E. Franges","doi":"10.1097/01.CCN.0000694084.86350.93","DOIUrl":"https://doi.org/10.1097/01.CCN.0000694084.86350.93","url":null,"abstract":"ABSTRACT\u0000Incomplete spinal cord injury is challenging to diagnose and treat. This overview of Brown-Séquard syndrome outlines key assessment and nursing considerations important to enhancing recovery outcomes.","PeriodicalId":19344,"journal":{"name":"Nursing Critical Care","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.CCN.0000694084.86350.93","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42804462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：